Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | PAM | P19021 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 4/20 | 0.39 |
| ▸ | CES1 | P23141 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31051576 | 0.98 | DGKA (0.47) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL15874693 | 0.98 | DGKA (0.47) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL3634120 | 0.98 | DGKA (0.47) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL29606730 | 0.98 | DGKA (0.43) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL17085777 | 0.98 | DGKA (0.47) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL5393249 | 0.98 | DGKA (0.47) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL5156066 | 0.98 | DGKA (0.47) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL1982508 | 0.97 | DGKA (0.46) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL1987495 | 0.97 | DGKA (0.46) | DGKAMAPTALDH1A1THRBCNR1 | |
| SCHEMBL22325579 | 0.97 | DGKA (0.46) | DGKAMAPTALDH1A1THRBCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676435-A1 | PERSONAL CARE COMPOSITION | The Procter & Gamble Company (US) | 2026-01-14 | — | — | EP | claimed |
| EP-4676436-A1 | PERSONAL CARE COMPOSITION | The Procter & Gamble Company (US) | 2026-01-14 | — | — | EP | claimed |
| WO-2024187075-A1 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2024-09-12 | — | — | WO | claimed |
| US-20240299285-A1 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2024-09-12 | — | — | US | claimed |
| WO-2024187076-A1 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2024-09-12 | — | — | WO | claimed |
| US-20240299272-A1 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2024-09-12 | — | — | US | claimed |
| EP-3551162-B1 | COMPOSITION SUITABLE FOR CLEANSING | OREAL (FR) | 2024-06-26 | — | — | EP | claimed |
| CN-113892029-A | Mass spectrometry method for detecting metabolites | 梅塔博隆股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| EP-4731176-A1 | COMPOSITION COMPRISING GLYCOLIPID, TAURATE SURFACTANT, AND AMINO ACID SURFACTANT | L'OREAL (FR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731173-A1 | COMPOSITION COMPRISING LOW MOLECULAR WEIGHT POLYLYSINE AND GLYCOLIPIDS | L'OREAL (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-20260076887-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | PROCTER & GAMBLE (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260062648-A1 | Dissolvable Solid Cleansing Articles Containing Taurate Surfactants | PROCTER & GAMBLE (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4676435-A1 | PERSONAL CARE COMPOSITION | The Procter & Gamble Company (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4676436-A1 | PERSONAL CARE COMPOSITION | The Procter & Gamble Company (US) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024187075-A1 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2024-09-12 | — | — | WO | disclosed |
| US-20240299285-A1 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2024-09-12 | — | — | US | disclosed |
| EP-3551162-B1 | COMPOSITION SUITABLE FOR CLEANSING | OREAL (FR) | 2024-06-26 | — | — | EP | disclosed |
| EP-3977112-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | Metabolon Inc. (US) | 2022-04-06 | — | — | EP | disclosed |
| CN-113892029-A | Mass spectrometry method for detecting metabolites | 梅塔博隆股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| WO-2020242744-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | METABOLON, INC. (US) | 2020-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299272-A1 | PERSONAL CARE COMPOSITION | TAF1, POLH, KAT7 | DGKA 2670/4885MAPT 215/4885ALDH1A1 4394/4885 |
| US-20260062648-A1 | Dissolvable Solid Cleansing Articles Containing Taurate Surfactants | SLC6A6, PHOSPHO1, SGMS2 | DGKA 222/4885MAPT 30/4885ALDH1A1 4124/4885 |
| US-20260076887-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | CUTA, PHOSPHO1, MGLL | DGKA 2226/4885MAPT 3145/4885ALDH1A1 4478/4885 |
| US-20240299285-A1 | PERSONAL CARE COMPOSITION | KAT7, SMURF1, CUTA | DGKA 2070/4885MAPT 83/4885ALDH1A1 3832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.